Genetic variation in catechol-O-methyltransferase modifies effects of clonidine treatment in chronic fatigue syndrome

Clonidine, an α2-adrenergic receptor agonist, decreases circulating norepinephrine and epinephrine, attenuating sympathetic activity. Although catechol-O-methyltransferase (COMT) metabolizes catecholamines, main effectors of sympathetic function, COMT genetic variation effects on clonidine treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, Kathryn T., Kossowsky, Joe, Oberlander, Tim F., Kaptchuk, Ted J., Saul, J. Philip, Wyller, Vegard Bruun, Fagermoen, Even, Sulheim, Dag, Gjerstad, Johannes, Winger, Anette, Mukamal, Kenneth J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028250/
https://www.ncbi.nlm.nih.gov/pubmed/27457818
http://dx.doi.org/10.1038/tpj.2016.53

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5028250/
https://www.ncbi.nlm.nih.gov/pubmed/27457818
http://dx.doi.org/10.1038/tpj.2016.53

Ejemplares similares